Cite
Influence of the watch and wait strategy on clinical outcomes of patients with follicular lymphoma in the rituximab era.
MLA
Yuda, Sayako, et al. “Influence of the Watch and Wait Strategy on Clinical Outcomes of Patients with Follicular Lymphoma in the Rituximab Era.” Annals of Hematology, vol. 95, no. 12, Dec. 2016, pp. 2017–22. EBSCOhost, https://doi.org/10.1007/s00277-016-2800-1.
APA
Yuda, S., Maruyama, D., Maeshima, A., Makita, S., Kitahara, H., Miyamoto, K., Fukuhara, S., Munakata, W., Suzuki, T., Kobayashi, Y., Tajima, K., Taniguchi, H., Tobinai, K., & Maeshima, A. M. (2016). Influence of the watch and wait strategy on clinical outcomes of patients with follicular lymphoma in the rituximab era. Annals of Hematology, 95(12), 2017–2022. https://doi.org/10.1007/s00277-016-2800-1
Chicago
Yuda, Sayako, Dai Maruyama, Akiko Maeshima, Shinichi Makita, Hideaki Kitahara, Ken-ichi Miyamoto, Suguru Fukuhara, et al. 2016. “Influence of the Watch and Wait Strategy on Clinical Outcomes of Patients with Follicular Lymphoma in the Rituximab Era.” Annals of Hematology 95 (12): 2017–22. doi:10.1007/s00277-016-2800-1.